Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gadd, S. L.
Right arrow Articles by Miller, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gadd, S. L.
Right arrow Articles by Miller, M. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 66, 233-243 (2002)
Copyright © 2002 by the Society of Toxicology


MOLECULAR AND GENETIC TOXICOLOGY

Acetaminophen-Induced Proliferation of Estrogen-Responsive Breast Cancer Cells Is Associated with Increases in c-myc RNA Expression and NF-{kappa}B Activity

Samantha L. Gadd*, Gerry Hobbs{dagger} and Michael R. Miller*,{ddagger},1

* Department of Biochemistry and Molecular Pharmacology and {dagger} Department of Community Medicine, West Virginia University, Morgantown, West Virginia; and {ddagger} National Institute of Occupational Safety and Health, Health Effects Laboratory Division, Morgantown, West Virginia

Studies reported here tested the hypothesis that acetaminophen stimulates proliferation of E2-responsive cells by inducing expression of E2-regulated genes. Ribonuclease protection assays compared the effects of acetaminophen and E2 on expression of selected genes (c-myc, c-fos, cyclin D1, bcl-2, bax, gadd45, mcl-1, p53, p21CIP1/WAF1, and bcl-xL) in E2-responsive breast cancer (MCF-7) and endometrial adenocarcinoma (Ishikawa) cells as well as in E2-nonresponsive (MDA-MB-231) breast cancer cells. Acetaminophen and E2 increased c-myc RNA levels in MCF-7 cells, consistent with a mitogenic activity of these compounds in MCF-7 cells. However, the magnitude and time course of acetaminophen and E2 induction of c-myc differed. Neither acetaminophen nor E2 induced c-myc in MDA-MB-231 cells, whereas E2, but not acetaminophen, weakly induced c-myc expression in Ishikawa cells. Furthermore, in these 3 cell types, the expression patterns of the other genes differed dramatically in response to acetaminophen and to E2, indicating that acetaminophen does not activate ER as a transcription factor in the same manner as does E2. Additionally, gel shift assays demonstrated that in MCF-7 cells, acetaminophen increased NF-{kappa}B activity ~40% and did not alter AP-1 activity, whereas E2 increased AP-1 activity ~50% and did not increase NF-B activity. These studies indicate that acetaminophen effects on gene expression and cell proliferation depend more on cell type/context than on the presence of ER.

Key Words: acetaminophen; estrogen receptor; c-myc gene; NF-{kappa}B; cell cycle.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
C. J. Bowman, N. J. Barlow, K. J. Turner, D. G. Wallace, and P. M. D. Foster
Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat
Toxicol. Sci., August 1, 2003; 74(2): 393 - 406.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Dowdy, S. Brower, and M. R. Miller
Acetaminophen Exhibits Weak Antiestrogenic Activity in Human Endometrial Adenocarcinoma (Ishikawa) Cells
Toxicol. Sci., March 1, 2003; 72(1): 57 - 65.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.